S&P 500 slips as healthcare drags, investors eye G20 summit

S&P 500 slips as healthcare drags, investors eye G20 summit
NEW YORK (Reuters) – The S&P 500 edged lower on Monday as losses by healthcare companies overshadowed gains in the technology sector, while investors awaited U.S. President Donald Trump’s meeting with Chinese President Xi Jinping at the G20 summit this week. Traders work on the floor at the New York Stock Exchange (NYSE) in New York, U.S., June 24, 2019.... Read More

Wall Street struggles for direction ahead of G20 summit

Wall Street struggles for direction ahead of G20 summit
NEW YORK (Reuters) – Wall Street struggled for direction on Monday as gains by technology companies were blunted by losses in the healthcare sector, while investors looked to U.S. President Donald Trump’s meeting with his Chinese counterpart Xi Jinping at the G20 summit later this week. Traders work on the floor at the New York Stock Exchange (NYSE) in New... Read More

Wall St. flat as healthcare losses limit tech gains

Wall St. flat as healthcare losses limit tech gains
(Reuters) – Wall Street’s main indexes were flat on Monday, as losses in healthcare stocks offset gains in the technology sector, while investors awaited a high-stakes meeting between U.S. and Chinese leaders at the G20 summit later this week. Traders work on the floor at the New York Stock Exchange (NYSE) in New York, U.S., June 24, 2019. REUTERS/Brendan McDermid... Read More

Wall Street edges higher as tech offsets healthcare loss

Wall Street edges higher as tech offsets healthcare loss
(Reuters) – U.S. stocks posted slight gains on Monday, as technology stocks more than offset a decline in healthcare sector, while investors awaited a high-stakes meeting between U.S. and Chinese leaders at the G20 summit later this week. FILE PHOTO: Traders work on the main trading floor after the opening bell at New York Stock Exchange (NYSE) in New York,... Read More

Illiquid assets held by Woodford’s UK fund pose hurdle to reopening

Illiquid assets held by Woodford’s UK fund pose hurdle to reopening
LONDON (Reuters) – Trading in Neil Woodford’s 3.7 billion pound ($4.69 billion) Equity Income Fund may not be reopened swiftly after it was suspended on June 3 because of the illiquid assets it holds. Neil Woodford, founder and fund manager at Woodford Investment Management, is seen in this undated handout picture released on June 10, 2019. Jonathan Atkins/Handout via REUTERS... Read More

Lords of the Ring: Can ‘smart’ ring give BlackRock fund managers the edge?

Lords of the Ring: Can ‘smart’ ring give BlackRock fund managers the edge?
LONDON (Reuters) – After years of using the internet, satellites, algos and other innovations to mine ‘Big Data’ for that edge over rivals, the world’s biggest investment firm is trialing a gizmo that puts the focus back on humans — its own portfolio managers. FILE PHOTO: A sign for BlackRock Inc hangs above their building in New York U.S., July... Read More

Fed officials face weak inflation, but split over what it means

Fed officials face weak inflation, but split over what it means
WASHINGTON/SAN FRANCISCO (Reuters) – U.S. Federal Reserve officials were divided Friday over how seriously to treat a slide in inflation, with one top policymaker saying the Fed was “close” to its inflation target and three others warning the weak price increases posed major risks the Fed may need to attack with lower interest rates. FILE PHOTO: President of the Federal... Read More

Soft U.S. factory activity darkens economic outlook

Soft U.S. factory activity darkens economic outlook
WASHINGTON (Reuters) – U.S. manufacturing activity barely grew in early June and the service sector cooled, signs that President Donald Trump’s trade war with China could be weighing on the economy. FILE PHOTO: A line worker checks frames for imperfections at Nissan Motor Co’s automobile manufacturing plant in Smyrna, Tennessee, U.S., August 23, 2018. REUTERS/William DeShazer/File Photo Other economic data... Read More

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries
NEW YORK (Reuters) – Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices in other countries would face legal challenges if adopted. FILE PHOTO: Ken Frazier, Chairman and CEO, Merck & Co., speaks during a meeting of the... Read More